Volume 5, Issue 2, June 2019, Page: 50-53
Profile and Prevalence of Dyslipidemia in Workplace in Togo
Wasungu Bassokla Ditorguéna, Occupational Health Office, Ornamental’s Stones and Marble Enterprise, Lome, Togo
Bana-ewai Essozimna Guy, Occupational Health Office, Togo’s Telecommunication Enterprise, Lomé, Togo
Agbobli Yawo Apélété, Department of Medicine and Specialties, University of Lomé, Lomé, Togo
Dadjo Soukouna Francis, Labor and Social Laws Department, Lomé, Togo
Atta Borgatia, Cardiology Office, CHU Sylvanus Olympio, Lomé, Togo
Pessinaba Souleymane, Cardiology Office, CHU Campus, Lomé, Togo
Amevor Kodjo, Occupational Health Office, Togo’s Telecommunication Enterprise, Lomé, Togo
Wognin Sangah, UFR Medical Sciences, University of Félix Houphouët Boigny, Abidjan, Côte d’Ivoire
Bonny Jean-Sylvain, UFR Medical Sciences, University of Félix Houphouët Boigny, Abidjan, Côte d’Ivoire
Received: Apr. 5, 2019;       Accepted: Jun. 2, 2019;       Published: Jun. 20, 2019
DOI: 10.11648/j.jher.20190502.13      View  193      Downloads  21
Abstract
Objectives: Dyslipidemia constitute a public health problem in the world. Very few studies were carried out on this subject in workplace. This work completed in workplace aimed to determine the prevalence of the dyslipidemia in workplace, to describe dyslipidemic profile in workers and its associated factors. Materials and Methods: It was about a descriptive cross-sectional study led June to September 2017 (04 months) on the medical files of the workers of a company of telephony in Togo. Were included the medical files comprising all the parameters of the lipidic assessment (total cholesterol, of triglycerides, the LDL and HDL cholesterol). The incomplete files were excluded. The dyslipidemia was defined for a total cholesterol higher than or 2, 4 g/L (6, 2 mmol/L) and/or a rate of HDL cholesterol lower than 0, 4 g/L (1 mmol/L) at the man or lower than 0, 50 g/L (1, 3 mmol/L) at the woman and/or a triglyceride higher than 2 g/L (2, 3 mmol/L) and/or a rate of LDLc > 1, 88 g/L. Results: The average age of the workers was 46, 57 years ± 7, 7 (extreme of 28 and 60 years). The administrative staff was prevalent in a proportion of 53, 4%. The pure hypercholesterolemia were most frequent (64%), followed by hypo HDL cholesterol and mixed dyslipidemia respectively 16,4% and 12,9%. The dyslipidemia was isolated in 72% from the cases, was combined with another factor of cardiovascular risk such as arterial hypertension (20, 2%), diabete (7, 1%) and an ischaemic cardiopathy (1, 1%) of the cases. Conclusion: Dyslipidemias are a reality in occupational environment in Togo with high prevalence estimated at 60.3% and are associated to other factor of cardiovascular risk such as arterial hypertension, diabete, and overweight. So it seems necessary to lead occupational health programs in order to control them.
Keywords
Dyslipidemia, Prevalence, Workplace, Prevention
To cite this article
Wasungu Bassokla Ditorguéna, Bana-ewai Essozimna Guy, Agbobli Yawo Apélété, Dadjo Soukouna Francis, Atta Borgatia, Pessinaba Souleymane, Amevor Kodjo, Wognin Sangah, Bonny Jean-Sylvain, Profile and Prevalence of Dyslipidemia in Workplace in Togo, Journal of Health and Environmental Research. Vol. 5, No. 2, 2019, pp. 50-53. doi: 10.11648/j.jher.20190502.13
Copyright
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
P. K. Streatfield, W. A Khan, A. Bhuiya, S. M. A. Hanifi and al. Noncommunicable Disease Mortality in Africa and Asia: Evidence from INDEPTH Health and Demographic Surveillance Systems. Global Health Action, 7, 25365.
[2]
P. K. Streatfield, W. A. Khan, A. Bhuiya, N. Alam and al. Cause-specific mortality in Africa and Asia: evidence from INDEPTH health and demographic surveillance system sites. Global Health Action, 7, 25362.
[3]
S. B Gning, M. Thiam, F. Fall, K. Ba-Fall, P. S. Mbaye, L. Fourcade. Diabetes mellitus in sub-Saharan Africa, epidemiological aspects, management difficulties. Med Trop 2007; 67: 607-611.
[4]
K. Steyn, K. Sliwa, S. Hawken S and al. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation 2005; 112: 3554-61.
[5]
J. E. Touze. Cardiovascular diseases and the epidemiological transition of the tropical world. Med Trop 2007; 67: 541-542.
[6]
WHO. Quantifying selected major risks to health. In: The WHO Report 2002- Reducing risks, promoting healthy life. Chap 4: Geneva: WHO; 2002. p. 47-97.
[7]
C. Scheidt-Nave, Y. Du, H. Knopf, A. Schienkiewitz, T. Ziese, E. Nowossadeck, A. Gößwald, MA. Busch. Prevalence of dyslipidemia among adults in Germany: Results of the German Health Interview and Examination Survey for Adults (DEGS 1). BGG. 2012; 56 (5 6): 325 30.
[8]
YS. Khader, A. Batieha, M. El-Khateeb, M. Al Omari, K. Ajlouni. Prevalence of dyslipidemia and its associated factors among Jordanian adults. J Clin Lipidol. 2010; 4 (1): 53-8.
[9]
A. Yahia-Berrouiguet, M. Benyoucef, K. Meguenni, B. Faivre, M. Brouri. Survey on the prevalence of risk factors for cardiovascular diseases in Tlemcen (Algeria). Diabetes Metab. 2009; 35 (1): 42-3.
[10]
MS / WHO. Noncommunicable Disease Survey Report according to the WHO STEPwise Approach? Study of arterial hypertension, diabetes and other risk factors in Nouakchott Mauritania. 2006.
[11]
F. Cisse, FD, Agne, A. Diatta, AS. Mbengue, A. Ndiaye, A. Samba, S. Thiam, D. Doupa, GN. Sarr, ND. Sall, M. Toure. Prevalence of dyslipidemias at the biochemistry laboratory of Aristide le Dantec University Hospital in Dakar, Senegal. Pan Afr Med J 2016; 25: 67.
[12]
A. Mbaye, M. B. Ndiaye, A. D. Kane, F. Ndoume, S. Diop, N. V. Yameogo, A. Kane. Occupational medicine around the world. Screening for cardiovascular risk factors among workers of a private telecommunications company in Senegal. Arch Mal Prof 2011; 72: 96-99.
[13]
G. Tiahou, K. Deret, A. World, M. Agniwo Camara-Cisse, Y. Djohan, P. Djessou, D. SESS. Frequency of lipid balances and prevalence of dyslipidemias in the biochemistry laboratory of the Cocody chu. J Sci Pharm Biol. 2010; 11 (2): 60-5.
[14]
FB. Micah, BC. Nkum. Lipid disorders in hospital waiting in Kumasi, Ghana. Ghana Medical Journal. 2012; 46 (1): 14-21.
[15]
Oguejiofor OC, Onwukwe CH, Odenigbo CU. Dyslipidemia in Nigeria: prevalence and pattern. Ann Afr Med. 2012; 11 (4): 197 202.
[16]
F. Damorou, E. Togbossi, S. Pessinaba, Y. Klouvi, A. Balogou, M. Belo, B. Soussou. Strokes and Cardiovascular Emboligens. Mali Medical 2008; 23 (1): 31-33.
[17]
F. Damorou, E. Togbossi, S. Pessinaba, B. Soussou. Epidemiology and circumstances of discovery of high blood pressure hypertension in hospitals in Kpalimé (secondary city of Togo). Mali Medical 2008; 23 (4): 17-20.
[18]
Republic of Togo. Inter-Ministerial Order No. 004/2011 / MTESS / MS establishing a safety and health service at work, in accordance with Articles 175 and 178 of the Labor Code.
[19]
C. Andryszak, E. Morel. Relevance of the exploration of lipid abnormalities by an occupational health service. doi: Arch. Wrong. Teacher. Approx. 10.1016 / j.admp.2012.03.141.
[20]
K. Agoudavi and al. Final report of STEPS Togo 2010 survey. Ministry of Health, Togo 2012.
[21]
A. Balaka, MA. Djibril, T. Tchamdja, KA. Djagadou, E. Mossi, KD. Nemi. Ischemic heart disease and dyslipidemia in a postal professional environment in Togo. RAFMI 2017; 4 (1-2): 7-9.
[22]
J. Ferrieres, JB. Ruidavets, B. Perret, J. Dallongeville, D. Arveiler, A. Bingham, P. Amouyel, B. Haas. Prevalence of dyslipidemias in a representative sample of the French population. Heart and Vessel Archives 2005; 98 (2): 127-132.
[23]
KM. Anderson, WP. Castelli, D. Levy. Cholesterol and Mortality: 30 years of follow-up from the Framingham study. JAMA. 1987; 257 (16): 2176-80.
[24]
G. Assmann, P. Cullen, H. Schulte. The Munster Heart Study (PROCAM): Results of follow-up at 8 years. Eur Heart J. 1998; 19 (substitute A): A2-A11.
[25]
C. Peretti, C. Perel, F. Chin, P. Tuppin, MC. Iliou, M. Vernay, and al. Average LDL cholesterol and the prevalence of LDL hypercholesterolemia in adults aged 18 to 74, National Nutrition and Health Study (ENHS) 2006-2007, Metropolitan France. BEH 2013; (31): 378-85.
[26]
A. Aouba, M. Eb, G. Rey, G. Pavillon, E. Jougla. Data on mortality in France: main causes of death in 2008 and developments since 2000. BEH.
[27]
Y. Gao, XN. Zhong, YH. Yang, KC. Tian. Plasma lipid level and incidence of dyslipidemia in workers of Chongqing enterprises and institutions. Zhonghua xin xue Guan Bing za zhi 2012; 40 (5): 432-435.
[28]
L. P Thiombiano, A. Mbaye, S. A. Sarr, A. A. Ngaide, Ab. Kane, M. Diao, Ad. Kane, S. A. Ba. Prévalence de la dyslipidémie dans la population rurale de Guéoul (Sénégal). Annales de Cardiologie et d’Angéiologie 2016; 65 (2): 77-80.
[29]
D. Doupa, A. S. Mbengue, F. A. Diallo, M. Jobe, A. Ndiaye, A. Kane, A. Diatta, M. Touré. Lipid profile frequency and the prevalence of dyslipidemia from biochemical tests at Saint Louis University Hospital in Senegal. Pan African Medical Journal 2014; 17: 75.
[30]
N. Mezghanni, M. Mnif, A. Lahiani, A. Lassouad, M. Kamoun, K. Jamoussi, F. Ayadi, H. Mejdoub, M. Abid. Effet du mode de vie active ou sédentaire sur le profil lipidique chez la femme obèse. Diabetes & Metabolism 2011; volume 37 (1): A37–38. Disponible: http://www.diabet metabolism.com/article/S1262363611706358/fulltext.
[31]
E. Asma, H. M. Dhouha, M. Anwar, N. Fadoua, D. Wahiba, G. Lotfi, F. N. Mohamed. Obésité et dyslipidémie chez des patients bipolaires tunisiens. Annales de Biologie Clinique 2011; 68 (3): 277-84.
[32]
C. Erem, A. Hacihasanoglu, O. Deger, M. Kocak, M. Topbas. Prevalence of dyslipidemias and associated risk factors among Turkish adults: Trabzon Lipid Study. Endocrine. 2008; 34 (1-3): 36–51.
[33]
S. L. Sauter, Jr J. J. Hurrel, L. R. Murphy, L. Levi. Les facteurs psychosociaux et organisationnels. In: Encyclopédie de la sécurité et de la santé au travail. Genève: Bureau International du Travail, 3è édition française, vol II, 2000, 34. 2.
[34]
K. Rouffiac, G. Boudet, P. Bailly, I. Biat, F. Dutheil, A. Chamoux. Détection des sujets à haut risque cardiovasculaire: bilan de sept années de dépistage actif et stratégie d’action en milieu de travail. Arch. Mal. Prof. Env 2012; 73: 339-343.
Browse journals by subject